Key points
- CEO Jamie Dimon’s unprecedented $150 million stock sale at JPMorgan Chase & Co. raises eyebrows among investors.
- Despite the recent insider selling, JPMorgan shares continue their upward trajectory, up nearly 8% this year and nearly 30% over the past year.
- Analysts maintain a Moderate Buy rating, but consensus price targets call for a slight downside, signaling mixed sentiment towards the banking giant.
- 5 stocks we prefer to JPMorgan Chase & Co.
Recent insiderselling activity at JPMorgan Chase & Co. New York Stock Exchange: JPMa major banking and financial institution, has attracted considerable attention, with CEO Jamie Dimon making his first stock sale since taking over leadership 18 years ago.
Dimon sold approximately $150 million worth of stock, or approximately 822,000 shares, while retaining approximately 7.7 million shares of the company’s stock. Under Dimon’s tenure, which began in 2006, the company’s assets and stock value tripled, with record profits reported and sustained value delivered to shareholders.
The CEO cited financial diversification and tax planning as reasons for the sale, expressing confidence in the company’s strong prospects. Further insider selling was observed, including by other top executives such as general board member Stacey Friedman and insider Lori Beer, indicating a broader trend within the company.
So, amid the recent insider selling, with the financial giant up an impressive 7.82% year-to-date and nearly 30% year-over-year, is it time to be cautious on the stock? Let’s take a closer look.
Snapshot of JPMorgan & Co.
JPMorgan Chase & Co. is the largest bank in the United States and the fifth largest globally. It is the result of mergers with its older predecessor, The Bank of The Manhattan Company, founded in 1799. Operating through four segments, it offers services in 48 U.S. states and globally through branches, ATMs, online, mobile and telephone services .
The company recently reported its earnings, falling short of analysts’ expectations with earnings per share of $3.04 for the quarter, compared to $3.73 expected. Despite revenue of $38.57 billion, slightly below the consensus estimate of $39.73 billion, the company posted an 11.7% year-over-year increase.
With trailing-twelve-month earnings per share of $16.22 and a price-to-earnings ratio of 11.3, JPMorgan Chase & Co. is expected to post modest earnings growth of 0.25% next year, from 15 .87 at $15.91 per share.
A technical perspective
While insiderselling made headlines and perhaps even shocked some investors and stakeholders, you couldn’t tell from the graph.
Over a broader timeframe, shares of the banking giant have been on a steady uptrend, trading solidly above its key simple moving averages (SMA). More recently, the stock is up nearly 8% this year and nearly 30% over the previous year. The insider selling news had little to no impact on the stock, with the stock up nearly 6.5% over the month.
So, even though the news made headlines in several newspapers, the market was not at all concerned about the sales.
It is worth noting, however, that JPM currently has an RSI of 73.71, placing it in overbought territory. The stock is also starting to extend from the rising 50-day and 200-day SMAs, suggesting overbought conditions and making it susceptible to a pullback.
Analysts remain bullish
The company has a Moderate Buy rating based on nineteen analyst ratings. Notably, this consensus rating is higher than that of other financial companies in the S&P 500, with a consensus rating of hold, and the consensus rating of the S&P 500 is also a hold rating.
While the rating is relatively bullish, the consensus price target is not. The consensus price target calls for a decline for the first time in over a year. Analysts’ consensus price target of $179.11 calls for a downside of 2.36% for JPM.
However, maintaining the bullish rating, recent analyst actions have been favorable. On February 1, the Goldman Sachs Group reiterated its buy rating. On January 30, both Oppenheimer and Morgan Stanley increased their targets, with the former raising its target to $238 and the latter to $221, both predicting significant upside potential.
Before you consider JPMorgan Chase & Co., you’ll want to hear this.
MarketBeat tracks daily Wall Street’s highest-rated and best-performing research analysts and the stocks they recommend to their clients. MarketBeat identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market takes hold… and JPMorgan Chase & Co. wasn’t on the list.
While JPMorgan Chase & Co. currently has a “Moderate Buy” rating among analysts, top-rated analysts believe these five stocks are better buys.
View the five stocks here
Do you expect global energy demand to decrease?! If not, it’s time to take a look at how energy stocks can play a role in your portfolio.
Get this free report